busulfan has been researched along with Aspergillus Infection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klaudel-Dreszler, MA | 1 |
| Kalwak, K | 1 |
| Kurenko-Deptuch, M | 1 |
| Wolska-Kusnierz, B | 1 |
| Heropolitanska-Pliszka, E | 1 |
| Pietrucha, B | 1 |
| Mikoluc, B | 1 |
| Gorczyńska, E | 1 |
| Ussowicz, M | 1 |
| Chybicka, A | 1 |
| Bernatowska, E | 1 |
| Kang, EM | 1 |
| Choi, U | 1 |
| Theobald, N | 1 |
| Linton, G | 1 |
| Long Priel, DA | 1 |
| Kuhns, D | 1 |
| Malech, HL | 1 |
| Ridola, V | 1 |
| Grill, J | 1 |
| Doz, F | 1 |
| Gentet, JC | 1 |
| Frappaz, D | 1 |
| Raquin, MA | 1 |
| Habrand, JL | 1 |
| Sainte-Rose, C | 1 |
| Valteau-Couanet, D | 1 |
| Kalifa, C | 1 |
| Yamasaki, S | 1 |
| Heike, Y | 1 |
| Mori, S | 1 |
| Fukuda, T | 1 |
| Maruyama, D | 1 |
| Kato, R | 1 |
| Usui, E | 1 |
| Koido, K | 1 |
| Kim, S | 1 |
| Tanosaki, R | 1 |
| Tobinai, K | 1 |
| Teshima, T | 1 |
| Takaue, Y | 1 |
| de Medeiros, CR | 1 |
| Dantas da Cunha, A | 1 |
| Pasquini, R | 1 |
| Arns da Cunha, C | 1 |
| Finley, R | 1 |
| Kieff, E | 1 |
| Thomsen, S | 1 |
| Fennessy, J | 1 |
| Beem, M | 1 |
| Lerner, S | 1 |
| Morello, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease[NCT00394316] | Early Phase 1 | 3 participants (Actual) | Interventional | 2006-10-30 | Terminated | ||
| Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency[NCT01306019] | Phase 1/Phase 2 | 19 participants (Actual) | Interventional | 2012-09-25 | Suspended (stopped due to Clones representing 10% or more of the subject patients myeloid lineage have been detected, no evidence of malignancy found.) | ||
| A Multicentric, Exploratory, Non-randomised, Non-controlled, Prospective, Open-label Phase II Study Evaluating Safety and Efficacy of IBU, G-CSF and Plerixafor as Stem Cell Mobilization Regimen in Patients Affected by X-CGD[NCT03055247] | Phase 2 | 3 participants (Anticipated) | Interventional | 2015-11-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for busulfan and Aspergillus Infection
5 other studies available for busulfan and Aspergillus Infection
| Article | Year |
|---|---|
Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC.
Topics: Antineoplastic Agents, Alkylating; Aspergillosis; Busulfan; Child, Preschool; Graft Survival; Granul | 2009 |
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Busulfan; Cerebellar Neoplasms; Child | 2007 |
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Topics: Adolescent; Adult; Aged; Aspergillosis; Bacteremia; Busulfan; Catheterization, Central Venous; Chron | 2008 |
Primary renal aspergillosis: extremely uncommon presentation in patients treated with bone marrow transplantation.
Topics: Aspergillosis; Aspergillus; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; F | 1999 |
Bronchial brushing in the diagnosis of pulmonary disease in patients at risk for opportunistic infection.
Topics: Aspergillosis; Bacterial Infections; Biopsy; Busulfan; Chickenpox; Coccidioidomycosis; Herpes Simple | 1974 |